All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| SGNT / Sagent Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CSBK / Clifton Bancorp Inc.
|
|
|
|
|
|
|
|
| US04351G1013 / Ascena Retail Group, Inc.
|
|
|
|
|
|
|
|
| THC / Tenet Healthcare Corporation
|
|
|
|
|
|
|
|
| 375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
|
|
|
|
|
|
|
|
| 91911K102 / Bausch Health Companies
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| SYNE / Synthesis Energy Systems, Inc.
|
|
|
|
|
|
|
|
| LULU / lululemon athletica inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| H03579101 / Auris Medical Holding Ltd
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
| RLYP / Relypsa, Inc.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
| VCRA / Vocera Communication Inc
|
|
|
|
|
|
|
|
| OREX / Orexigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| XLE / The Select Sector SPDR Trust - The Energy Select Sector SPDR Fund Put
|
|
|
|
|
|
|
|
| PRLB / Proto Labs, Inc.
|
|
|
|
|
|
|
|
| WFC.PRL / Wells Fargo & Company - Preferred Stock
|
|
|
|
|
|
|
|
| 368682AN0 / Ajrd 4.0625 12/31/2039 Bond
|
|
|
|
|
|
|
|
| SAAS / inContact, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| LDRH / iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF
|
|
|
|
|
|
|
|
| / Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
| KSU / Kansas City Southern
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| ZTS / Zoetis Inc.
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| VTVT / vTv Therapeutics Inc.
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
